Chromatin modifications as therapeutic targets in MLL-rearranged leukemia

Kouzarides, 2007, Chromatin modifications and their function, Cell, 128, 693, 10.1016/j.cell.2007.02.005 Chi, 2010, Covalent histone modifications – miswritten, misinterpreted and mis-erased in human cancers, Nat. Rev. Cancer, 10, 457, 10.1038/nrc2876 Issa, 2005, Azacitidine, Nat. Rev. Drug Discov., 4, 275, 10.1038/nrd1698 Gore, 2006, Decitabine, Nat. Rev. Drug Discov., 5, 891, 10.1038/nrd2180 Marks, 2010, The clinical development of histone deacetylase inhibitors as targeted anticancer drugs, Expert Opin. Investig. Drugs, 19, 1049, 10.1517/13543784.2010.510514 Boumber, 2011, Epigenetics in cancer: what's the future?, Oncology (Williston Park), 25, 220 Daigle, 2011, Selective killing of mixed lineage leukemia cells by a potent small-molecule DOT1L inhibitor, Cancer Cell, 20, 53, 10.1016/j.ccr.2011.06.009 Dawson, 2011, Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia, Nature, 478, 529, 10.1038/nature10509 Zuber, 2011, RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia, Nature, 478, 524, 10.1038/nature10334 Harris, 2012, The histone demethylase KDM1A sustains the oncogenic potential of MLL-AF9 leukemia stem cells, Cancer Cell, 21, 473, 10.1016/j.ccr.2012.03.014 Biondi, 2000, Biological and therapeutic aspects of infant leukemia, Blood, 96, 24, 10.1182/blood.V96.1.24 Balgobind, 2009, Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study, Blood, 114, 2489, 10.1182/blood-2009-04-215152 Armstrong, 2002, MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia, Nat. Genet., 30, 41, 10.1038/ng765 Ferrando, 2003, Gene expression signatures in MLL-rearranged T-lineage and B-precursor acute leukemias: dominance of HOX dysregulation, Blood, 102, 262, 10.1182/blood-2002-10-3221 Nakamura, 2002, ALL-1 is a histone methyltransferase that assembles a supercomplex of proteins involved in transcriptional regulation, Mol. Cell, 10, 1119, 10.1016/S1097-2765(02)00740-2 Milne, 2002, MLL targets SET domain methyltransferase activity to Hox gene promoters, Mol. Cell, 10, 1107, 10.1016/S1097-2765(02)00741-4 Miller, 2001, COMPASS: a complex of proteins associated with a trithorax-related SET domain protein, Proc. Natl. Acad. Sci. U.S.A., 98, 12902, 10.1073/pnas.231473398 Xia, 2003, MLL repression domain interacts with histone deacetylases, the polycomb group proteins HPC2 and BMI-1, and the corepressor C-terminal-binding protein, Proc. Natl. Acad. Sci. U.S.A., 100, 8342, 10.1073/pnas.1436338100 Dou, 2005, Physical association and coordinate function of the H3 K4 methyltransferase MLL1 and the H4 K16 acetyltransferase MOF, Cell, 121, 873, 10.1016/j.cell.2005.04.031 Ernst, 2001, MLL and CREB bind cooperatively to the nuclear coactivator CREB-binding protein, Mol. Cell. Biol., 21, 2249, 10.1128/MCB.21.7.2249-2258.2001 Meyer, 2009, New insights to the MLL recombinome of acute leukemias, Leukemia, 23, 1490, 10.1038/leu.2009.33 Cheung, 2007, Protein arginine-methyltransferase-dependent oncogenesis, Nat. Cell Biol., 9, 1208, 10.1038/ncb1642 Krivtsov, 2007, MLL translocations, histone modifications and leukaemia stem-cell development, Nat. Rev. Cancer, 7, 823, 10.1038/nrc2253 Somervaille, 2010, Grist for the MLL: how do MLL oncogenic fusion proteins generate leukemia stem cells?, Int. J. Hematol., 91, 735, 10.1007/s12185-010-0579-8 Slany, 2009, The molecular biology of mixed lineage leukemia, Haematologica, 94, 984, 10.3324/haematol.2008.002436 Bitoun, 2007, The mixed-lineage leukemia fusion partner AF4 stimulates RNA polymerase II transcriptional elongation and mediates coordinated chromatin remodeling, Hum. Mol. Genet., 16, 92, 10.1093/hmg/ddl444 Mueller, 2007, A role for the MLL fusion partner ENL in transcriptional elongation and chromatin modification, Blood, 110, 4445, 10.1182/blood-2007-05-090514 Mueller, 2009, Misguided transcriptional elongation causes mixed lineage leukemia, PLoS Biol., 7, e1000249, 10.1371/journal.pbio.1000249 Mohan, 2010, Linking H3K79 trimethylation to Wnt signaling through a novel Dot1-containing complex (DotCom), Genes Dev., 24, 574, 10.1101/gad.1898410 Lin, 2010, AFF4, a component of the ELL/P-TEFb elongation complex and a shared subunit of MLL chimeras, can link transcription elongation to leukemia, Mol. Cell, 37, 429, 10.1016/j.molcel.2010.01.026 Yokoyama, 2010, A higher-order complex containing AF4 and ENL family proteins with P-TEFb facilitates oncogenic and physiologic MLL-dependent transcription, Cancer Cell, 17, 198, 10.1016/j.ccr.2009.12.040 Monroe, 2011, MLL-AF9 and MLL-ENL alter the dynamic association of transcriptional regulators with genes critical for leukemia, Exp. Hematol., 39, 77, 10.1016/j.exphem.2010.09.003 Biswas, 2011, Function of leukemogenic mixed lineage leukemia 1 (MLL) fusion proteins through distinct partner protein complexes, Proc. Natl. Acad. Sci. U.S.A., 108, 15751, 10.1073/pnas.1111498108 Chang, 2010, Histone H3 lysine 79 methyltransferase Dot1 is required for immortalization by MLL oncogenes, Cancer Res., 70, 10234, 10.1158/0008-5472.CAN-10-3294 Thiel, 2010, MLL-AF9-induced leukemogenesis requires coexpression of the wild-type Mll allele, Cancer Cell, 17, 148, 10.1016/j.ccr.2009.12.034 Yokoyama, 2005, The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis, Cell, 123, 207, 10.1016/j.cell.2005.09.025 Tan, 2011, CBX8, a polycomb group protein, is essential for MLL-AF9-induced leukemogenesis, Cancer Cell, 20, 563, 10.1016/j.ccr.2011.09.008 Muntean, 2010, The PAF complex synergizes with MLL fusion proteins at HOX loci to promote leukemogenesis, Cancer Cell, 17, 609, 10.1016/j.ccr.2010.04.012 Grembecka, 2012, Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemia, Nat. Chem. Biol., 8, 277, 10.1038/nchembio.773 Bres, 2008, The multi-tasking P-TEFb complex, Curr. Opin. Cell Biol., 20, 334, 10.1016/j.ceb.2008.04.008 Wang, 2010, Flavopiridol, the first cyclin-dependent kinase inhibitor: recent advances in combination chemotherapy, Mini Rev. Med. Chem., 10, 1058, 10.2174/1389557511009011058 Rizzolio, 2010, CDK inhibitors: from the bench to clinical trials, Curr. Drug Targets, 11, 279, 10.2174/138945010790711978 Nakanishi, 2007, ALL1 fusion proteins induce deregulation of EphA7 and ERK phosphorylation in human acute leukemias, Proc. Natl. Acad. Sci. U.S.A., 104, 14442, 10.1073/pnas.0703211104 Stubbs, 2008, MLL-AF9 and FLT3 cooperation in acute myelogenous leukemia: development of a model for rapid therapeutic assessment, Leukemia, 22, 66, 10.1038/sj.leu.2404951 Wang, 2008, Glycogen synthase kinase 3 in MLL leukaemia maintenance and targeted therapy, Nature, 455, 1205, 10.1038/nature07284 Wang, 2010, The Wnt/beta-catenin pathway is required for the development of leukemia stem cells in AML, Science, 327, 1650, 10.1126/science.1186624 Yeung, 2010, beta-Catenin mediates the establishment and drug resistance of MLL leukemic stem cells, Cancer Cell, 18, 606, 10.1016/j.ccr.2010.10.032 Liedtke, 2009, Therapeutic targeting of MLL, Blood, 113, 6061, 10.1182/blood-2008-12-197061 Muntean, 2012, The pathogenesis of mixed-lineage leukemia, Annu. Rev. Pathol., 7, 283, 10.1146/annurev-pathol-011811-132434 Feng, 2002, Methylation of H3-lysine 79 is mediated by a new family of HMTases without a SET domain, Curr. Biol., 12, 1052, 10.1016/S0960-9822(02)00901-6 Lacoste, 2002, Disruptor of telomeric silencing-1 is a chromatin-specific histone H3 methyltransferase, J. Biol. Chem., 277, 30421, 10.1074/jbc.C200366200 van Leeuwen, 2002, Dot1p modulates silencing in yeast by methylation of the nucleosome core, Cell, 109, 745, 10.1016/S0092-8674(02)00759-6 Ng, 2002, Lysine methylation within the globular domain of histone H3 by Dot1 is important for telomeric silencing and Sir protein association, Genes Dev., 16, 1518, 10.1101/gad.1001502 Okada, 2005, hDOT1L links histone methylation to leukemogenesis, Cell, 121, 167, 10.1016/j.cell.2005.02.020 Okada, 2006, Leukaemic transformation by CALM-AF10 involves upregulation of Hoxa5 by hDOT1L, Nat. Cell Biol., 8, 1017, 10.1038/ncb1464 Zeisig, 2005, The eleven-nineteen-leukemia protein ENL connects nuclear MLL fusion partners with chromatin, Oncogene, 24, 5525, 10.1038/sj.onc.1208699 Zhang, 2006, Dot1a-AF9 complex mediates histone H3 Lys-79 hypermethylation and repression of ENaCalpha in an aldosterone-sensitive manner, J. Biol. Chem., 281, 18059, 10.1074/jbc.M601903200 Reisenauer, 2009, AF17 competes with AF9 for binding to Dot1a to up-regulate transcription of epithelial Na+ channel alpha, J. Biol. Chem., 284, 35659, 10.1074/jbc.M109.038448 Krivtsov, 2008, H3K79 methylation profiles define murine and human MLL-AF4 leukemias, Cancer Cell, 14, 355, 10.1016/j.ccr.2008.10.001 Guenther, 2008, Aberrant chromatin at genes encoding stem cell regulators in human mixed-lineage leukemia, Genes Dev., 22, 3403, 10.1101/gad.1741408 Milne, 2005, Leukemogenic MLL fusion proteins bind across a broad region of the Hox a9 locus, promoting transcription and multiple histone modifications, Cancer Res., 65, 11367, 10.1158/0008-5472.CAN-05-1041 Bernt, 2011, MLL-rearranged leukemia is dependent on aberrant H3K79 methylation by DOT1L, Cancer Cell, 20, 66, 10.1016/j.ccr.2011.06.010 Nguyen, 2011, DOT1L, the H3K79 methyltransferase, is required for MLL-AF9-mediated leukemogenesis, Blood, 117, 6912, 10.1182/blood-2011-02-334359 Jo, 2011, Requirement for Dot1l in murine postnatal hematopoiesis and leukemogenesis by MLL translocation, Blood, 117, 4759, 10.1182/blood-2010-12-327668 Chang, 2010, Histone H3 lysine 79 methyltransferase Dot1 is required for immortalization by MLL oncogenes, Cancer Res., 70, 10234, 10.1158/0008-5472.CAN-10-3294 Yao, 2011, Selective inhibitors of histone methyltransferase DOT1L: design, synthesis, and crystallographic studies, J. Am. Chem. Soc., 133, 16746, 10.1021/ja206312b Wang, 2010, Pro isomerization in MLL1 PHD3-bromo cassette connects H3K4me readout to CyP33 and HDAC-mediated repression, Cell, 141, 1183, 10.1016/j.cell.2010.05.016 Muntean, 2008, The PHD fingers of MLL block MLL fusion protein-mediated transformation, Blood, 112, 4690, 10.1182/blood-2008-01-134056 Stumpel, 2012, Connectivity mapping identifies HDAC inhibitors for the treatment of t(4;11)-positive infant acute lymphoblastic leukemia, Leukemia, 26, 682, 10.1038/leu.2011.278 Burbury, 2011, MLL-aberrant leukemia: complete cytogenetic remission following treatment with a histone deacetylase inhibitor (HDACi), Ann. Hematol., 90, 847, 10.1007/s00277-010-1099-6 Yang, 2005, Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4, Mol. Cell, 19, 535, 10.1016/j.molcel.2005.06.029 French, 2008, BRD-NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells, Oncogene, 27, 2237, 10.1038/sj.onc.1210852 Filippakopoulos, 2010, Selective inhibition of BET bromodomains, Nature, 468, 1067, 10.1038/nature09504 Nicodeme, 2010, Suppression of inflammation by a synthetic histone mimic, Nature, 468, 1119, 10.1038/nature09589 Delmore, 2011, BET bromodomain inhibition as a therapeutic strategy to target c-Myc, Cell, 146, 904, 10.1016/j.cell.2011.08.017 Jang, 2005, The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription, Mol. Cell, 19, 523, 10.1016/j.molcel.2005.06.027 Tan, 2011, Identification of 67 histone marks and histone lysine crotonylation as a new type of histone modification, Cell, 146, 1016, 10.1016/j.cell.2011.08.008 Bernt, 2011, MLL-rearranged leukemia is dependent on aberrant H3K79 methylation by DOT1L, Cancer Cell, 20, 66, 10.1016/j.ccr.2011.06.010 Dawson, 2011, Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia, Nature, 478, 529, 10.1038/nature10509 Jo, 2011, Requirement for Dot1l in murine postnatal hematopoiesis and leukemogenesis by MLL translocation, Blood, 117, 4759, 10.1182/blood-2010-12-327668 Nguyen, 2011, Essential role of DOT1L in maintaining normal adult hematopoiesis, Cell Res., 21, 1370, 10.1038/cr.2011.115 Chase, 2011, Aberrations of EZH2 in cancer, Clin. Cancer Res., 17, 2613, 10.1158/1078-0432.CCR-10-2156 Morishita, 2011, Cancers and the NSD family of histone lysine methyltransferases, Biochim. Biophys. Acta, 1816, 158 Lucio-Eterovic, 2011, An open and shut case for the role of NSD proteins as oncogenes, Transcription, 2, 158, 10.4161/trns.2.4.16217 Iyer, 2004, p300/CBP and cancer, Oncogene, 23, 4225, 10.1038/sj.onc.1207118 Yang, 2007, MOZ and MORF, two large MYSTic HATs in normal and cancer stem cells, Oncogene, 26, 5408, 10.1038/sj.onc.1210609 van Haaften, 2009, Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer, Nat. Genet., 41, 521, 10.1038/ng.349 Chapman, 2011, Initial genome sequencing and analysis of multiple myeloma, Nature, 471, 467, 10.1038/nature09837 Wartman, 2011, Sequencing a mouse acute promyelocytic leukemia genome reveals genetic events relevant for disease progression, J. Clin. Invest., 121, 1445, 10.1172/JCI45284 Mar, 2012, Sequencing histone-modifying enzymes identifies UTX mutations in acute lymphoblastic leukemia, Leukemia, 10.1038/leu.2012.56 van Zutven, 2006, Identification of NUP98 abnormalities in acute leukemia: JARID1A (12p13) as a new partner gene, Genes Chromosomes Cancer, 45, 437, 10.1002/gcc.20308 He, 2011, KDM2b/JHDM1b, an H3K36me2-specific demethylase, is required for initiation and maintenance of acute myeloid leukemia, Blood, 117, 3869, 10.1182/blood-2010-10-312736 Wang, 2009, Haematopoietic malignancies caused by dysregulation of a chromatin-binding PHD finger, Nature, 459, 847, 10.1038/nature08036 Briggs, 2002, Gene silencing: trans-histone regulatory pathway in chromatin, Nature, 418, 498, 10.1038/nature00970 He, 2011, Human polymerase-associated factor complex (PAFc) connects the super elongation complex (SEC) to RNA polymerase II on chromatin, Proc. Natl. Acad. Sci. U.S.A., 108, E636, 10.1073/pnas.1107107108 Tan, 2010, PAFc, a key player in MLL-rearranged leukemogenesis, Oncotarget, 1, 461, 10.18632/oncotarget.181